Recent advances in dosage form design for the elderly: a review
Introduction With the increase in the elderly population and the prevalence of multiple
medical conditions, medication adherence, and efficacy have become crucial for the …
medical conditions, medication adherence, and efficacy have become crucial for the …
Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges—A Narrative Review
KVS Hodel, BSD Fiuza, RS Conceição, ACM Aleluia… - Pharmaceuticals, 2024 - mdpi.com
Pharmacovigilance plays a central role in safeguarding public health by continuously
monitoring the safety of vaccines, being critical in a climate of vaccine hesitancy, where …
monitoring the safety of vaccines, being critical in a climate of vaccine hesitancy, where …
[HTML][HTML] Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
D Li, J Gou, J Zhu, T Zhang, F Liu, D Zhang… - Frontiers in …, 2023 - frontiersin.org
Background: Sound drug safety information is important to optimize patient management,
but the widely recognized comprehensive landscape of culprit-drugs that cause severe …
but the widely recognized comprehensive landscape of culprit-drugs that cause severe …
[HTML][HTML] Real-world use of ruxolitinib cream: safety analysis at 1 year
W Hu, M Thornton, RA Livingston - American Journal of Clinical …, 2024 - Springer
Background Ruxolitinib cream is the first topical Janus kinase (JAK) inhibitor approved in the
United States (US) for the treatment of mild to moderate atopic dermatitis and nonsegmental …
United States (US) for the treatment of mild to moderate atopic dermatitis and nonsegmental …
[HTML][HTML] Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
D Li, S Chai, H Wang, J Dong, C Qin, D Du… - Frontiers in …, 2023 - frontiersin.org
Introduction: Drug-induced QT prolongation and (or) Torsade de Pointes (TdP) is a well-
known serious adverse reaction (ADR) for some drugs, but the widely recognized …
known serious adverse reaction (ADR) for some drugs, but the widely recognized …
[HTML][HTML] Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database
R Ruggiero, A Mascolo, A Spezzaferri, C Carpentieri… - Pharmaceuticals, 2024 - mdpi.com
Background: A potential risk of suicide associated with liraglutide or semaglutide treatments
has recently emerged. Therefore, we decided to investigate the reporting probability of …
has recently emerged. Therefore, we decided to investigate the reporting probability of …
Postmarket safety profile of suicide/self-injury for GLP-1 receptor agonist: a real-world pharmacovigilance analysis
C Chen, R Zhou, F Fu, J Xiao - European psychiatry, 2023 - cambridge.org
BackgroundRecent reports of individuals experiencing suicidal and/or self-injurious
behaviors while using liraglutide and semaglutide have heightened the concerns regarding …
behaviors while using liraglutide and semaglutide have heightened the concerns regarding …
Predictive Modeling of Drug‐Related Adverse Events with Real‐World Data: A Case Study of Linezolid Hematologic Outcomes
Electronic health records (EHRs) provide meaningful knowledge of drug‐related adverse
events (AEs) that are not captured in standard drug development and postmarketing …
events (AEs) that are not captured in standard drug development and postmarketing …
[HTML][HTML] The International Working Group on New Developments in Pharmacovigilance: Advancing Methods and Communication in Pharmacovigilance
D Cooper, RW Platt, F van Hunsel, M Davies… - Clinical …, 2024 - Elsevier
ABSTRACT Purpose In 2019, the International Working Group (IWG), focusing on New
Developments in Pharmacovigilance, was established. This group is coordinated by the …
Developments in Pharmacovigilance, was established. This group is coordinated by the …
[HTML][HTML] CDK4/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug–gene interaction network
Y She, Z Guo, Q Zhai, J Liu, Q Du… - Frontiers in Pharmacology, 2024 - frontiersin.org
Objective: The aim of this study was to investigate the potential risk of drug-induced liver
injury (DILI) caused by the CDK4/6 inhibitors (CDK4/6is abemaciclib, ribociclib, and …
injury (DILI) caused by the CDK4/6 inhibitors (CDK4/6is abemaciclib, ribociclib, and …